Friday 18 May |
Paddy Power Betfair |
Independent News & Media |
AstraZeneca |
Computacenter |
Clarke (T) |
Petrofac |
John Menzies |
Derwent London |
Hikma Pharmaceuticals |
NEX Group (re acquisition by CME London) |
Monday 21 May |
BP |
Cloudcall Group |
Restore |
4D Pharma |
TBC Bank Group |
Secure Income REIT |
Tuesday 22 May |
Xaar |
Gulf Marine Services |
Menhaden Capital |
Forterra |
Stock Spirits Group |
Gocompare.com |
Arrow Global Group |
Fidelity Japanese Values |
Accesso Technology Group |
Wednesday 23 May |
Bovis Homes Group |
St James's Place |
Keller Group |
Gamma Communications |
Antofagasta |
Fundsmith Emerging Equities Trust |
Hilton Food Group |
Mercantile Investment Trust |
Polypipe Group |
Smart Metering Systems |
XLMedia |
Restaurant Group |
Central Asia Metals |
Allied Minds |
Xeros Technology Group |
Medica Group |
Bakkavor |
NAHL Group |
Boku |
Thursday 24 May |
Lloyds Banking Group |
Balfour Beatty |
Sound Energy |
Ibstock |
Sportech |
Alliance Pharma |
Henry Boot |
Enquest |
Hastings Group |
Headlam group |
Huntsworth |
Inchcape |
Intertek |
Spire Healthcare |
Tissue Regenix Group |
Learning Technologies Group |
Sabre Insurance Group |
eve Sleep |
Cambridge Cognition |
Arena Events |
Strix Group |
Yu Group |
Tissue Regenix's losses widen as company pushes towards significant milestones
(ShareCast News) - AIM-listed regenerative medical devices company Tissue Regenix Group's saw operating losses widen at the interim stage even as its revenues nudged higher, although it did gain regulatory approval for its products in Europe and the US. For the six months ended 31 July, revenue incr
Read more